Letter to the Editor Regarding “The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence”Barbara Finck, Paul Walden, Robert B. Geller|Advances in Therapy|2021Cited by 2